Given the high recurrence rate of CRC post-surgery and the existing knowledge gaps about recurrence mechanisms, our study aimed to elucidate the relationship between elevated PROX1 and α-SMA expression, cancer progression, clinical outcomes, and their influence on CAFs in the CRC TME. The gene discussed is ACTA1; the disease is colorectal carcinoma.